In addition, the CHD patient (TOF) carrying this mutation may offer a valuable chance to examine the relationship between TGF-β1 mediated fibrosis, aging processes and SCN5A in human heart, a possibility suggested by recent findings in Scn5a knockout animal models23, 40, 41, 42. Here, SCN5A is linked to coronary artery disorder.